Becton, Dickinson and Co. | BDX - Sales Revenues


Becton, Dickinson and Co. reported $5B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Agilent USD 1.88B 43M Jun/2026
Align Technology USD 1.06B 20M Jun/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Bio-Rad Laboratories USD 651M 58.9M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Danaher USD 6.55B 254M Sep/2026
Dentsply International USD 898M 18M Jun/2026
Dexcom USD 1.31B 120M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
J&J USD 25.4B 89M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Solventum Corp USD 2.2B 190M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Terumo JPY 311.81B 11.49B Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026